News

You can filter the posts based on tags:

Macrophages as a therapeutic key for lung cancer

Lung cancer is considered the most frequently lethal tumor disease. ILH scientists have shown that the reprogramming of a specific group of white blood cells, known as tumor-associated macrophages, could be a promising approach for cancer therapy.

2023-10-05

Pulmonary hypertension: Molecular investigation of the remodelling processes in the heart

ILH scientist Prof. Dr. Soni Savai Pullamsetti and her team have discovered signalling pathways involved in developing right heart failure in patients with pulmonary hypertension. The findings provide new biomarkers for diagnosis and targets for future therapies.

2023-10-04

How the lungs defend themselves against bacteria

A group led by Marburg-based ILH/DZL researcher Professor Dr Bernd Schmeck has studied how the respiratory tract reacts to infection with pneumococci, the most important pathogen causing pneumonia.

2023-09-30

Previously unknown cause for the development of pulmonary fibrosis discovered

Researchers have discovered a mechanism that promotes the development of pulmonary fibrosis. An innovative therapeutic approach based on this discovery showed promising results in a preclinical study.

2023-09-27

Institute for Lung Health gets a home

A new building for the Institute for Lung Health (ILH) is being constructed at the DZL site in Gießen, Marburg, Bad Nauheim.

2023-09-27

Prof. Soni Savai Pullamsetti, a new member of the Leopoldina

The National Academy of Sciences Leopoldina is Germany's oldest scientific and medical-learned society. ILH researcher Prof. Pullamsetti was admitted to the prestigious Leopoldina.

2023-09-25

New treatment approach for pulmonary hypertension: slowing harmful remodeling processes in the heart

ILH researchers have found that inhibiting a signaling pathway reduces pathological remodeling of the right ventricle in pulmonary hypertension.

2023-09-21

Develop antifibrotic drugs faster

In combination with single-cell technology, human tissue models will accelerate the translation of new antifibrotic agents in the future.

« Previous 1 … 5 6 7 8 9 10 Next »

2023-09-25

New treatment approach for pulmonary hypertension: slowing harmful remodeling processes in the heart

ILH researchers have found that inhibiting a signaling pathway reduces pathological remodeling of the right ventricle in pulmonary hypertension.

2023-09-21

Develop antifibrotic drugs faster

In combination with single-cell technology, human tissue models will accelerate the translation of new antifibrotic agents in the future.

2023-07-06

Rajkumar Savai receives the „Mid-Career Achievement Award“ of the American Thoracic Society (ATS)

Professor Rajkumar Savai, MD, was awarded the Thoracic Oncology “Mid-Career Achievement Award” for his significant and meaningful contribution to thoracic oncology research at the 2023 Annual Meeting of the American Thoracic Society (ATS) International Conference in Washington, DC, USA.

2023-06-12

Why most smokers do not get COPD

An enzyme in alveoli cells protects most smokers from chronic obstructive pulmonary disease (COPD).

2023-06-08

First Integrated Single-Cell Atlas of the Human Lung

DZL/ILH researchers at Helmholtz Munich and their collaborators developed the Human Lung Cell Atlas using artificial intelligence (AI)-based techniques. This atlas elucidates the diversity of single lung cell types and allows learning about lung biology in health and disease.

2022-06-14

Ausgezeichnete Leistungen: DZL-Wissenschaftlerinnen und Wissenschaftler erhalten Preise im Rahmen des 62. DGP-Kongresses

Vom 25.-28. Mai 2022 präsentierte sich das DZL mit Informationsstand, Vorträgen, Postern und weiteren Aktionen beim 62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) in Leipzig.

2022-05-20

10 Jahre DZG: "Tempomacher in der Gesundheitsforschung"

Vier von sechs Deutschen Zentren der Gesundheitsforschung (DZG) feierten gestern mit einem Festakt in Berlin und rund 300 Gästen aus Politik und Wissenschaft ihren zehnten Geburtstag.

2022-03-14

LOEWE top professorship for Prof. Susanne Herold

Thanks to million euro funding from the state of Hesse, Corona expert Susanne Herold remains at Justus Liebig University Giessen.

2022-02-17

Regulatory mechanisms in pulmonary blood vessels - new "player" identified

DZL scientists identified a new player within the pressure regulation in pulmonary vessels

« Previous 1 … 5 6 7 8 9 Next »

The Giessen Lung Research Hub is a vibrant cosmos of interlinked Lung & Infection Research activities on a top international scale.

More information

Archives